\-\ Texto\\:\\ \ \(0\)\
\-\ vital\\ signs\\:\\ within\\ normal\\ limits\ \(0\)\
\-\ physical\\ exam\\:\ \(1\)\
\-\ abdomen\\:\\ soft\\,\\ normoactive\\ bowel\\ sounds\\,\\ no\\ distention\\ or\\ organomegaly\\ appreciated\\.\\ mild\\ tenderness\\ to\\ palpation\\ diffusely\\ but\\ more\\ pronounced\\ in\\ the\\ suprapubic\\ area\\.\\ no\\ rebound\\ or\\ guarding\\ observed\ \(0\)\
\-\ other\\ systems\\ within\\ normal\\ limits\\.\\ \ \(0\)\
\-\ laboratory\\ results\\:\ \(0\)\
\-\ cbc\\,\\ cmp\\,\\ esr\\ and\\ crp\\ within\\ normal\\ limits\ \(0\)\
\-\ negative\\ stool\\ guaiac\\ and\\ normal\\ fecal\\ calprotectin\ \(0\)\
\-\ urinalysis\\ at\\ the\\ time\\ of\\ admission\\:\\ within\\ normal\\ limits\ \(0\)\
\-\ color\\:\\ yellow\ \(1\)\
\-\ appearance\\:\\ hazy\ \(1\)\
\-\ ph\\:\\ 7\\.0\ \(0\)\
\-\ glucose\\:\\ negative\ \(1\)\
\-\ ketones\\:\\ negative\ \(1\)\
\-\ bilirubin\\:\\ negative\ \(1\)\
\-\ nitrites\\:\\ negative\ \(1\)\
\-\ leukocyte\\ esterase\\:\\ moderate\ \(1\)\
\-\ blood\\:\\ negative\ \(1\)\
\-\ urobilinogen\\:\\ 0\\.2\\ \\(reference\\ range\\:\\ 0\\.2\\-1\\.0\\)\ \(0\)\
\-\ protein\\:\\ negative\ \(1\)\
\-\ specific\\ gravity\\:\\ 1\\.015\ \(1\)\
\-\ source\\:\\ clean\\ catch\ \(1\)\
\-\ urine\\ culture\\:\\ no\\ growth\\ after\\ 2\\ days\ \(0\)\
\-\ urologist\\ consulted\\ believed\\ that\\ patient\\&\\#39\\;s\\ symptoms\\ were\\ likely\\ unrelated\\ to\\ the\\ calcifications\\ noted\\ on\\ imaging\\ especially\\ since\\ urinalysis\\ was\\ benign\\.\\ there\\ was\\ no\\ evidence\\ of\\ obstruction\\ and\\ the\\ pain\\ experienced\\ by\\ the\\ patient\\ was\\ not\\ lateralized\\.\\ \ \(0\)\
\-\ no\\ follow\\ up\\ for\\ this\\ condition\\ was\\ recommended\\ since\\ patient\\&\\#39\\;s\\ symptoms\\ resolved\\ with\\ bowel\\ clean\\ out\\.\ \(0\)\
\-\ imaging\\ done\\ prior\\ to\\ admission\\:\ \(0\)\
\-\ abdominal\\ x\\-ray\\ 1\\:\\ several\\ unchanged\\ calcifications\\ present\\ in\\ lower\\ pelvis\\,\\ below\\ the\\ level\\ of\\ the\\ ischial\\ spines\\,\\ may\\ be\\ representative\\ of\\ phleboliths\\.\\ ultrasound\\ recommended\\ to\\ exclude\\ ovarian\\ or\\ bladder\\ calcifications\\.\\ see\\ figure\\ 1\\.\\ \ \(0\)\
\-\ abdominal\\ ultrasound\\:\\ multiple\\ calcific\\ densities\\.\\ significant\\ shadowing\\ associated\\ with\\ the\\ areas\\ of\\ previous\\ deflux\\ procedure\\ but\\ ureteral\\ stones\\ trapped\\ at\\ the\\ orifice\\ cannot\\ be\\ excluded\\.\\ see\\ figure\\ 2\\.\\ \ \(0\)\
\-\ abdominal\\ ct\\ stone\\ protocol\\:\\ uterus\\ and\\ ovaries\\ appear\\ normal\\,\\ multiple\\ pelvic\\ calcifications\\.\\ largest\\ calcification\\ appears\\ to\\ be\\ at\\ ureteral\\ inlet\\ on\\ left\\ side\\ in\\ the\\ bladder\\,\\ widest\\ dimension\\ approximately\\ 8mm\\.\\ similar\\ smaller\\ lesions\\ present\\ on\\ the\\ right\\ side\\,\\ 5mm\\ in\\ maximum\\ dimension\\.\\ single\\ calcification\\ in\\ high\\ right\\ pelvis\\ could\\ be\\ in\\ ureter\\ or\\ could\\ be\\ a\\ fecalith\\.\\ concern\\ for\\ bilateral\\ stone\\ disease\\.\\ intravenous\\ pyelogram\\ \\(ivp\\)\\ recommended\\ for\\ evaluation\\ for\\ possible\\ obstruction\\.\\ see\\ figures\\ 3\\ and\\ 4\\.\\ \ \(0\)\
\-\ ivp\\:\\ kidneys\\ and\\ ureters\\ normal\\ in\\ position\\ and\\ size\\,\\ no\\ delay\\ in\\ excretion\\ of\\ contrast\\.\\ calcifications\\ present\\ in\\ distal\\ ureters\\ bilaterally\\ without\\ evidence\\ of\\ obstruction\\.\\ see\\ figure\\ 5\\.\ \(0\)\
\-\ imaging\\ done\\ while\\ admitted\\:\ \(0\)\
\-\ abdominal\\ x\\-ray\\ after\\ bowel\\ clean\\ out\\:\\ pelvic\\ calcifications\\ consistent\\ with\\ ureteral\\ stones\\ again\\ identified\\.\\ see\\ figure\\ 6\\.\ \(0\)\
\-\ sequela\\ of\\ deflux\\ procedure\ \(0\)\
\-\ phlebothiasis\ \(0\)\
\-\ ureteral\\ stone\\ disease\ \(0\)\
\-\ sequela\\ of\\ deflux\\ procedure\ \(0\)\
\-\ this\\ 8\\ y\\.o\\.\\ girl\\ has\\ a\\ history\\ of\\ irritable\\ bowel\\ syndrome\\ and\\ bilateral\\ vesicoureteral\\ reflux\\,\\ addressed\\ with\\ a\\ deflux\\ procedure\\ during\\ early\\ infancy\\.\\ she\\ presents\\ with\\ diffuse\\ acute\\ worsening\\ abdominal\\ pain\\,\\ nausea\\,\\ and\\ intermittent\\ non\\-bilious\\,\\ non\\-bloody\\ emesis\\ for\\ 3\\ weeks\\.\\ \ \(0\)\
\-\ for\\ the\\ past\\ year\\,\\ patient\\ has\\ been\\ taking\\ daily\\ fiber\\ and\\ miralax\\ prn\\.\\ the\\ patient\\ was\\ recently\\ started\\ on\\ levsin\\ 0\\.125mg\\ tablet\\ every\\ 4\\ hours\\,\\ as\\ needed\\ for\\ pain\\ but\\ reported\\ no\\ improvement\\ in\\ symptoms\\.\\ abdominal\\ imaging\\ was\\ done\\ some\\ days\\ before\\ admission\\.\ \(0\)\
\-\ approximately\\ 1\\%\\ of\\ children\\ worldwide\\ have\\ vesicoureteral\\ reflux\\ \\(vur\\)\\ which\\ is\\ graded\\ via\\ voiding\\ cystourethrogram\\ \\(vcug\\)\\ from\\ grade\\ i\\ to\\ v\\ depending\\ on\\ how\\ retrograde\\ the\\ urine\\ is\\ able\\ to\\ travel\\ and\\ the\\ degree\\ of\\ ureteral\\ dilation\\.\\ \ \(0\)\
\-\ endoscopic\\ deflux\\ injection\\ has\\ been\\ associated\\ with\\ complications\\ including\\ hematuria\\,\\ both\\ gross\\ and\\ microscopic\\,\\ urinary\\ tract\\ infections\\,\\ rise\\ in\\ serum\\ creatinine\\ and\\ flank\\ pain\\.\\ rarely\\ complications\\ including\\ contralateral\\ vur\\ and\\ ureteral\\ obstruction\\ by\\ the\\ material\\ resulting\\ in\\ de\\ novo\\ hydronephrosis\\ have\\ been\\ observed\\ and\\ documented\\.\\ \ \(0\)\
\-\ there\\ are\\ now\\ also\\ reports\\,\\ including\\ this\\ one\\,\\ of\\ calcification\\ at\\ the\\ site\\ of\\ deflux\\ injection\\,\\ mimicking\\ stone\\ disease\\ on\\ imaging\\ but\\ without\\ associated\\ symptoms\\ or\\ signs\\ of\\ urinary\\ obstruction\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ deflux\\:\\ 0\\.3606912093990021\ \(0\)\
\-\ ureteral\\:\\ 0\\.23503556553215357\ \(0\)\
\-\ calcifications\\:\\ 0\\.16460601216964155\ \(0\)\
\-\ negative\\:\\ 0\\.1629036322664814\ \(0\)\
\-\ figure\\:\\ 0\\.15170214070226554\ \(0\)\
\-\ clean\\:\\ 0\\.13803804698542377\ \(0\)\
\-\ stone\\:\\ 0\\.13734365851666558\ \(0\)\
\-\ obstruction\\:\\ 0\\.13164966509399695\ \(0\)\
\-\ the\\:\\ 0\\.12751093009887524\ \(0\)\
\-\ abdominal\\:\\ 0\\.12335505679657703\ \(0\)\
\-\ procedure\\:\\ 0\\.11987584364530893\ \(0\)\
\-\ limits\\:\\ 0\\.11881068724681959\ \(0\)\
\-\ see\\:\\ 0\\.1169176794205511\ \(0\)\
\-\ and\\:\\ 0\\.11651387810814609\ \(0\)\
\-\ in\\:\\ 0\\.11221519990563472\ \(0\)\
\-\ of\\:\\ 0\\.11034406565806211\ \(0\)\
\-\ normal\\:\\ 0\\.10743530158939209\ \(0\)\
\-\ ivp\\:\\ 0\\.10371959223823\ \(0\)\
\-\ vur\\:\\ 0\\.10195971297329065\ \(0\)\
\-\ imaging\\:\\ 0\\.09877508499142404\ \(0\)\
\-\ bowel\\:\\ 0\\.09649538212468481\ \(0\)\
\-\ admission\\:\\ 0\\.09409030566759023\ \(0\)\
\-\ sequela\\:\\ 0\\.09282436789343561\ \(0\)\
\-\ recommended\\:\\ 0\\.08970411915584126\ \(0\)\
\-\ done\\:\\ 0\\.08970411915584126\ \(0\)\
\-\ no\\:\\ 0\\.08556774762463046\ \(0\)\
\-\ symptoms\\:\\ 0\\.08226930692739942\ \(0\)\
\-\ ureters\\:\\ 0\\.08177559404042306\ \(0\)\
\-\ vesicoureteral\\:\\ 0\\.08177559404042306\ \(0\)\
\-\ urinalysis\\:\\ 0\\.08142411942348302\ \(0\)\
\-\ including\\:\\ 0\\.08070461870653\ \(0\)\
\-\ calcification\\:\\ 0\\.08051360972722875\ \(0\)\
\-\ for\\:\\ 0\\.07975349044635738\ \(0\)\
\-\ was\\:\\ 0\\.07860371820305292\ \(0\)\
\-\ dimension\\:\\ 0\\.07754618527423142\ \(0\)\
\-\ be\\:\\ 0\\.0762445725523812\ \(0\)\
\-\ but\\:\\ 0\\.07435400721545873\ \(0\)\
\-\ stones\\:\\ 0\\.07096972269580216\ \(0\)\
\-\ within\\:\\ 0\\.06925188007272967\ \(0\)\
\-\ on\\:\\ 0\\.06811764049432675\ \(0\)\
\-\ urine\\:\\ 0\\.0672964146577053\ \(0\)\
\-\ observed\\:\\ 0\\.06694494004076526\ \(0\)\
\-\ to\\:\\ 0\\.065782648672144\ \(0\)\
\-\ been\\:\\ 0\\.06570174398491244\ \(0\)\
\-\ injection\\:\\ 0\\.0654183326538705\ \(0\)\
\-\ or\\:\\ 0\\.06538511980737363\ \(0\)\
\-\ reflux\\:\\ 0\\.06511300200122136\ \(0\)\
\-\ urinary\\:\\ 0\\.06501277705401474\ \(0\)\
\-\ 39\\:\\ 0\\.062477408416174114\ \(0\)\
\-\ patient\\:\\ 0\\.06113131817645862\ \(0\)\
\-\ calprotectin\\:\\ 0\\.06011520156650036\ \(0\)\
\-\ phlebothiasis\\:\\ 0\\.06011520156650036\ \(0\)\
\-\ levsin\\:\\ 0\\.06011520156650036\ \(0\)\
\-\ associated\\:\\ 0\\.05943884794333533\ \(0\)\
\-\ pelvic\\:\\ 0\\.05876852811075073\ \(0\)\
\-\ bladder\\:\\ 0\\.05834038550100756\ \(0\)\
\-\ present\\:\\ 0\\.05786653511477605\ \(0\)\
\-\ complications\\:\\ 0\\.0575803801914227\ \(0\)\
\-\ lateralized\\:\\ 0\\.057443284415069004\ \(0\)\
\-\ widest\\:\\ 0\\.057443284415069004\ \(0\)\
\-\ miralax\\:\\ 0\\.057443284415069004\ \(0\)\
\-\ at\\:\\ 0\\.056793450100358085\ \(0\)\
\-\ could\\:\\ 0\\.05468498110104258\ \(0\)\
\-\ since\\:\\ 0\\.05445891180103145\ \(0\)\
\-\ pyelogram\\:\\ 0\\.05407706690772466\ \(0\)\
\-\ pain\\:\\ 0\\.05380488580219986\ \(0\)\
\-\ ischial\\:\\ 0\\.05287561187514148\ \(0\)\
\-\ spines\\:\\ 0\\.05287561187514148\ \(0\)\
\-\ novo\\:\\ 0\\.05287561187514148\ \(0\)\
\-\ pelvis\\:\\ 0\\.052581880502107575\ \(0\)\
\-\ signs\\:\\ 0\\.052543060099832645\ \(0\)\
\-\ side\\:\\ 0\\.05193699851611401\ \(0\)\
\-\ irritable\\:\\ 0\\.051859796119115\ \(0\)\
\-\ has\\:\\ 0\\.05151057130240426\ \(0\)\
\-\ nitrites\\:\\ 0\\.050979856486645325\ \(0\)\
\-\ catch\\:\\ 0\\.050979856486645325\ \(0\)\
\-\ fecalith\\:\\ 0\\.050979856486645325\ \(0\)\
\-\ fiber\\:\\ 0\\.050979856486645325\ \(0\)\
\-\ mimicking\\:\\ 0\\.050979856486645325\ \(0\)\
\-\ urobilinogen\\:\\ 0\\.05020369472371013\ \(0\)\
\-\ worldwide\\:\\ 0\\.05020369472371013\ \(0\)\
\-\ cystourethrogram\\:\\ 0\\.05020369472371013\ \(0\)\
\-\ phleboliths\\:\\ 0\\.04950939436779714\ \(0\)\
\-\ out\\:\\ 0\\.04941737325152157\ \(0\)\
\-\ addressed\\:\\ 0\\.04888132329822129\ \(0\)\
\-\ tablet\\:\\ 0\\.04888132329822129\ \(0\)\
\-\ prn\\:\\ 0\\.04830793933521396\ \(0\)\
\-\ approximately\\:\\ 0\\.04797080026800267\ \(0\)\
\-\ suprapubic\\:\\ 0\\.047780477220217686\ \(0\)\
\-\ urologist\\:\\ 0\\.047780477220217686\ \(0\)\
\-\ days\\:\\ 0\\.047592673433600616\ \(0\)\
\-\ disease\\:\\ 0\\.04733731873765938\ \(0\)\
\-\ infancy\\:\\ 0\\.04729212357918748\ \(0\)\
\-\ gravity\\:\\ 0\\.04683747721636578\ \(0\)\
\-\ trapped\\:\\ 0\\.04683747721636578\ \(0\)\
\-\ ketones\\:\\ 0\\.046412183946717804\ \(0\)\
\-\ esterase\\:\\ 0\\.046412183946717804\ \(0\)\
\-\ orifice\\:\\ 0\\.046412183946717804\ \(0\)\
\-\ ultrasound\\:\\ 0\\.0463728886059014\ \(0\)\
\-\ guaiac\\:\\ 0\\.04601268232847459\ \(0\)\
\-\ representative\\:\\ 0\\.04601268232847459\ \(0\)\
\-\ 8mm\\:\\ 0\\.04601268232847459\ \(0\)\
\-\ normoactive\\:\\ 0\\.045636022183782605\ \(0\)\
\-\ fecal\\:\\ 0\\.045636022183782605\ \(0\)\
\-\ hazy\\:\\ 0\\.045636022183782605\ \(0\)\
\-\ figures\\:\\ 0\\.045636022183782605\ \(0\)\
\-\ voiding\\:\\ 0\\.045636022183782605\ \(0\)\
\-\ inlet\\:\\ 0\\.04527973225166902\ \(0\)\
\-\ leukocyte\\:\\ 0\\.044620206427756125\ \(0\)\
\-\ travel\\:\\ 0\\.04431365075829377\ \(0\)\
\-\ with\\:\\ 0\\.0441639984843997\ \(0\)\
\-\ ph\\:\\ 0\\.043212804680290165\ \(0\)\
\-\ unrelated\\:\\ 0\\.042964105032351256\ \(0\)\
\-\ excretion\\:\\ 0\\.04272445103925996\ \(0\)\
\-\ rise\\:\\ 0\\.04272445103925996\ \(0\)\
\-\ evidence\\:\\ 0\\.04267271233888425\ \(0\)\
\-\ graded\\:\\ 0\\.042493207715493905\ \(0\)\
\-\ vcug\\:\\ 0\\.042493207715493905\ \(0\)\
\-\ organomegaly\\:\\ 0\\.04226980467643826\ \(0\)\
\-\ microscopic\\:\\ 0\\.04226980467643826\ \(0\)\
\-\ pronounced\\:\\ 0\\.04205372766206352\ \(0\)\
\-\ cmp\\:\\ 0\\.04184451140679028\ \(0\)\
\-\ unchanged\\:\\ 0\\.04184451140679028\ \(0\)\
\-\ ovaries\\:\\ 0\\.04144500978854707\ \(0\)\
\-\ yellow\\:\\ 0\\.04125398892041178\ \(0\)\
\-\ consulted\\:\\ 0\\.04071205971174151\ \(0\)\
\-\ de\\:\\ 0\\.04071205971174151\ \(0\)\
\-\ bilateral\\:\\ 0\\.040404915001757274\ \(0\)\
\-\ bilirubin\\:\\ 0\\.040374049287942096\ \(0\)\
\-\ crp\\:\\ 0\\.040211330933700225\ \(0\)\
\-\ believed\\:\\ 0\\.040211330933700225\ \(0\)\
\-\ retrograde\\:\\ 0\\.040211330933700225\ \(0\)\
\-\ documented\\:\\ 0\\.040211330933700225\ \(0\)\
\-\ 5mm\\:\\ 0\\.040052533887828604\ \(0\)\
\-\ maximum\\:\\ 0\\.03989747359199857\ \(0\)\
\-\ how\\:\\ 0\\.03974597821836625\ \(0\)\
\-\ without\\:\\ 0\\.03965502464526021\ \(0\)\
\-\ calcific\\:\\ 0\\.039597887525006904\ \(0\)\
\-\ endoscopic\\:\\ 0\\.0393113311380324\ \(0\)\
\-\ this\\:\\ 0\\.03875019486624429\ \(0\)\
\-\ largest\\:\\ 0\\.03827551609951806\ \(0\)\
\-\ creatinine\\:\\ 0\\.03827551609951806\ \(0\)\
\-\ emesis\\:\\ 0\\.038156778499332446\ \(0\)\
\-\ densities\\:\\ 0\\.03759320802811904\ \(0\)\
\-\ contralateral\\:\\ 0\\.03759320802811904\ \(0\)\
\-\ have\\:\\ 0\\.03755691371334428\ \(0\)\
\-\ stool\\:\\ 0\\.037486055122136\ \(0\)\
\-\ excluded\\:\\ 0\\.036974965086422756\ \(0\)\
\-\ ureter\\:\\ 0\\.03687733724861955\ \(0\)\
\-\ guarding\\:\\ 0\\.03678113468572657\ \(0\)\
\-\ reference\\:\\ 0\\.03678113468572657\ \(0\)\
\-\ multiple\\:\\ 0\\.03677254625520091\ \(0\)\
\-\ protocol\\:\\ 0\\.03668631638048426\ \(0\)\
\-\ distention\\:\\ 0\\.03650067710392757\ \(0\)\
\-\ after\\:\\ 0\\.03647141940981738\ \(0\)\
\-\ culture\\:\\ 0\\.03640978244186265\ \(0\)\
\-\ taking\\:\\ 0\\.03640978244186265\ \(0\)\
\-\ every\\:\\ 0\\.03640978244186265\ \(0\)\
\-\ systems\\:\\ 0\\.03632012448028401\ \(0\)\
\-\ glucose\\:\\ 0\\.03632012448028401\ \(0\)\
\-\ exclude\\:\\ 0\\.03632012448028401\ \(0\)\
\-\ shadowing\\:\\ 0\\.03623167001766255\ \(0\)\
\-\ rebound\\:\\ 0\\.035806376748014575\ \(0\)\
\-\ source\\:\\ 0\\.035806376748014575\ \(0\)\
\-\ depending\\:\\ 0\\.035806376748014575\ \(0\)\
\-\ experienced\\:\\ 0\\.03572451534099238\ \(0\)\
\-\ daily\\:\\ 0\\.035643658393772704\ \(0\)\
\-\ diffusely\\:\\ 0\\.0349573992329048\ \(0\)\
\-\ protein\\:\\ 0\\.03488537929723041\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.03488537929723041\ \(0\)\
\-\ concern\\:\\ 0\\.0344690455918746\ \(0\)\
\-\ delay\\:\\ 0\\.0344690455918746\ \(0\)\
\-\ esr\\:\\ 0\\.03440214391550353\ \(0\)\
\-\ intravenous\\:\\ 0\\.03427034435163242\ \(0\)\
\-\ appreciated\\:\\ 0\\.03389006047381543\ \(0\)\
\-\ color\\:\\ 0\\.03389006047381543\ \(0\)\
\-\ smaller\\:\\ 0\\.033828759952496214\ \(0\)\
\-\ resolved\\:\\ 0\\.033768024420976435\ \(0\)\
\-\ serum\\:\\ 0\\.03370784355959054\ \(0\)\
\-\ again\\:\\ 0\\.033530529942412665\ \(0\)\
\-\ rarely\\:\\ 0\\.033530529942412665\ \(0\)\
\-\ vital\\:\\ 0\\.03347247002038263\ \(0\)\
\-\ gross\\:\\ 0\\.03335786263563886\ \(0\)\
\-\ hematuria\\:\\ 0\\.03324521444773479\ \(0\)\
\-\ infections\\:\\ 0\\.03318960434116171\ \(0\)\
\-\ dilation\\:\\ 0\\.033079772490014696\ \(0\)\
\-\ uterus\\:\\ 0\\.03297174124234135\ \(0\)\
\-\ able\\:\\ 0\\.03297174124234135\ \(0\)\
\-\ flank\\:\\ 0\\.03297174124234135\ \(0\)\
\-\ degree\\:\\ 0\\.03286545251031821\ \(0\)\
\-\ recently\\:\\ 0\\.03281294419646973\ \(0\)\
\-\ improvement\\:\\ 0\\.03281294419646973\ \(0\)\
\-\ kidneys\\:\\ 0\\.03235829783364803\ \(0\)\
\-\ ovarian\\:\\ 0\\.032025170521240466\ \(0\)\
\-\ by\\:\\ 0\\.03192611124821602\ \(0\)\
\-\ started\\:\\ 0\\.03166399747773503\ \(0\)\
\-\ material\\:\\ 0\\.03166399747773503\ \(0\)\
\-\ tract\\:\\ 0\\.031490572770980885\ \(0\)\
\-\ cbc\\:\\ 0\\.03136343522253008\ \(0\)\
\-\ resulting\\:\\ 0\\.03128001944387152\ \(0\)\
\-\ needed\\:\\ 0\\.031035926408159192\ \(0\)\
\-\ growth\\:\\ 0\\.030996109014981864\ \(0\)\
\-\ below\\:\\ 0\\.0309565307667492\ \(0\)\
\-\ admitted\\:\\ 0\\.030800552868951274\ \(0\)\
\-\ children\\:\\ 0\\.030800552868951274\ \(0\)\
\-\ intermittent\\:\\ 0\\.03072392690648161\ \(0\)\
\-\ via\\:\\ 0\\.03072392690648161\ \(0\)\
\-\ before\\:\\ 0\\.030389726692977282\ \(0\)\
\-\ site\\:\\ 0\\.03031770675730289\ \(0\)\
\-\ condition\\:\\ 0\\.030037249175503884\ \(0\)\
\-\ position\\:\\ 0\\.029968960911327232\ \(0\)\
\-\ there\\:\\ 0\\.029914191330013815\ \(0\)\
\-\ especially\\:\\ 0\\.02973537539506388\ \(0\)\
\-\ appear\\:\\ 0\\.029605523734997002\ \(0\)\
\-\ results\\:\\ 0\\.029291666393295345\ \(0\)\
\-\ reports\\:\\ 0\\.029230649674750638\ \(0\)\
\-\ range\\:\\ 0\\.02917019275050378\ \(0\)\
\-\ sounds\\:\\ 0\\.029021433419477403\ \(0\)\
\-\ single\\:\\ 0\\.028904797480455113\ \(0\)\
\-\ nausea\\:\\ 0\\.028875958228641682\ \(0\)\
\-\ worsening\\:\\ 0\\.028705523939329174\ \(0\)\
\-\ similar\\:\\ 0\\.0286496781938967\ \(0\)\
\-\ hours\\:\\ 0\\.0286496781938967\ \(0\)\
\-\ specific\\:\\ 0\\.028484925649633504\ \(0\)\
\-\ previous\\:\\ 0\\.02840406870241383\ \(0\)\
\-\ moderate\\:\\ 0\\.028219173568878854\ \(0\)\
\-\ appears\\:\\ 0\\.027527478375491098\ \(0\)\
\-\ laboratory\\:\\ 0\\.027297043759895872\ \(0\)\
\-\ early\\:\\ 0\\.027096324937807514\ \(0\)\
\-\ reported\\:\\ 0\\.027074395604685688\ \(0\)\
\-\ grade\\:\\ 0\\.027030754660273538\ \(0\)\
\-\ identified\\:\\ 0\\.026650470782456553\ \(0\)\
\-\ girl\\:\\ 0\\.02636915788771953\ \(0\)\
\-\ benign\\:\\ 0\\.025822054153049764\ \(0\)\
\-\ now\\:\\ 0\\.02580397524315943\ \(0\)\
\-\ areas\\:\\ 0\\.025521261281087827\ \(0\)\
\-\ possible\\:\\ 0\\.025469576635576367\ \(0\)\
\-\ size\\:\\ 0\\.025452438112205183\ \(0\)\
\-\ palpation\\:\\ 0\\.025350532599132152\ \(0\)\
\-\ bilaterally\\:\\ 0\\.025070075017333153\ \(0\)\
\-\ right\\:\\ 0\\.024925532812907308\ \(0\)\
\-\ several\\:\\ 0\\.024662977134823117\ \(0\)\
\-\ past\\:\\ 0\\.02446848660304481\ \(0\)\
\-\ area\\:\\ 0\\.02435159203420158\ \(0\)\
\-\ while\\:\\ 0\\.02429391325439796\ \(0\)\
\-\ during\\:\\ 0\\.023809662825531312\ \(0\)\
\-\ some\\:\\ 0\\.023651501028951336\ \(0\)\
\-\ tenderness\\:\\ 0\\.023573821247080205\ \(0\)\
\-\ diffuse\\:\\ 0\\.023573821247080205\ \(0\)\
\-\ abdomen\\:\\ 0\\.02293639636681849\ \(0\)\
\-\ evaluation\\:\\ 0\\.022924722743709443\ \(0\)\
\-\ level\\:\\ 0\\.0227067648220801\ \(0\)\
\-\ appearance\\:\\ 0\\.022661783360588206\ \(0\)\
\-\ syndrome\\:\\ 0\\.022661783360588206\ \(0\)\
\-\ weeks\\:\\ 0\\.022528652397879996\ \(0\)\
\-\ likely\\:\\ 0\\.02246308212034602\ \(0\)\
\-\ she\\:\\ 0\\.02237665781902629\ \(0\)\
\-\ time\\:\\ 0\\.022280766350599165\ \(0\)\
\-\ distal\\:\\ 0\\.02184094509756626\ \(0\)\
\-\ blood\\:\\ 0\\.021831057986151474\ \(0\)\
\-\ significant\\:\\ 0\\.021703857509988805\ \(0\)\
\-\ lesions\\:\\ 0\\.021588581826626572\ \(0\)\
\-\ one\\:\\ 0\\.02152225731325318\ \(0\)\
\-\ high\\:\\ 0\\.02136390920688657\ \(0\)\
\-\ mild\\:\\ 0\\.021308917856982655\ \(0\)\
\-\ prior\\:\\ 0\\.021031883822851836\ \(0\)\
\-\ both\\:\\ 0\\.020962242397718094\ \(0\)\
\-\ more\\:\\ 0\\.02064113936007911\ \(0\)\
\-\ is\\:\\ 0\\.02058876207481353\ \(0\)\
\-\ physical\\:\\ 0\\.020382367127154095\ \(0\)\
\-\ consistent\\:\\ 0\\.020382367127154095\ \(0\)\
\-\ acute\\:\\ 0\\.02033495858798689\ \(0\)\
\-\ follow\\:\\ 0\\.02026447921538713\ \(0\)\
\-\ soft\\:\\ 0\\.020012318559741688\ \(0\)\
\-\ noted\\:\\ 0\\.0199303645992813\ \(0\)\
\-\ other\\:\\ 0\\.019521288004947672\ \(0\)\
\-\ were\\:\\ 0\\.019376754870232136\ \(0\)\
\-\ lower\\:\\ 0\\.01920872540667858\ \(0\)\
\-\ exam\\:\\ 0\\.018923016250165747\ \(0\)\
\-\ may\\:\\ 0\\.018916664675195215\ \(0\)\
\-\ up\\:\\ 0\\.01859454468234569\ \(0\)\
\-\ contrast\\:\\ 0\\.018264398294067428\ \(0\)\
\-\ presents\\:\\ 0\\.018082913267377144\ \(0\)\
\-\ also\\:\\ 0\\.017681437583957123\ \(0\)\
\-\ which\\:\\ 0\\.01709271993399518\ \(0\)\
\-\ that\\:\\ 0\\.01631281535708032\ \(0\)\
\-\ as\\:\\ 0\\.015101389867682672\ \(0\)\
\-\ from\\:\\ 0\\.014929305392837532\ \(0\)\
\-\ not\\:\\ 0\\.01483978796530475\ \(0\)\
\-\ history\\:\\ 0\\.014361701413116093\ \(0\)\
\-\ ct\\:\\ 0\\.014311010712993592\ \(0\)\
\-\ are\\:\\ 0\\.01426383972759547\ \(0\)\
\-\ left\\:\\ 0\\.012822898570334916\ \(0\)\
\-\ year\\:\\ 0\\.011584615120420865\ \(0\)\
\-\ can\\:\\ 0\\.0\ \(0\)\
